Distribution of episodes of kidney diseases admitted at the University Hospital Center “Mother Teresa” in Tirana, Albania, during the period 2010-2023

Submitted: 15 August 2024
Accepted: 4 September 2024
Published: 16 September 2024
Abstract Views: 0
PDF: 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Our aim was to describe the distribution of kidney diseases among hospitalized patients in Tirana, the capital of Albania, during the period 2010-2023. A case-series study was conducted including all episodes admitted with kidney diseases at the University Hospital Center “Mother Teresa” in Tirana during the period 2010-2023 (overall: 15,763 episodes; 46% females; overall mean age: 54.0±17.3 years). We found that ≈56% of the kidney disease episodes were 35-65 years old, followed by >65-year-old individuals (≈28%). Most of the kidney disease episodes (about 43%) hospitalized were from the Tirana region, followed by districts pertinent to South Albania (23%). Older patients (>65 years) were more prevalent among males compared to females (301% vs 25%, respectively; p<0.001). Patients from the Tirana region were more prevalent among females compared to males (45% vs 42%, respectively, p<0.001). This study provides evidence on the distribution of the episodes of kidney diseases admitted at University Hospital Center “Mother Teresa” in Tirana, the largest region in Albania, a country in the Western Balkans that is undergoing deep reforms in all sectors, including also the health sector.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Rajesh K, Spring KJ, Beran RG, Bhaskar SMM. Chronic kidney disease prevalence and clinical outcomes in anterior circulation acute ischemic stroke patients with reperfusion therapy: a meta-analysis. Nephrology (Carlton) 2024;29:21-33.
Haileamlak A. Chronic Kidney Disease is on the rise. Ethiop J Health Sci 2018;28:681-2.
Global Burden of Disease (GBD) 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1545.
Kelly DM, Pendlebury ST, Rothwell PM. Associations of chronic kidney disease with dementia before and after TIA and Stroke: population-based cohort study. Neurology 2022;98:e711-20.
Fandler-Höfler S, Odler B, Kneihsl M, et al. Acute and chronic kidney dysfunction and outcome after stroke thrombectomy. Transl Stroke Res 2021;12:791-8.
Gela YY, Tesfaye W, Melese M, et al. Common mental disorders and associated factors among adult chronic kidney disease patients attending referral hospitals in Amhara Regional State. Sci Rep 2024;14:6812.
Abbas Tavallaii S, Ebrahimnia M, Shamspour N, Assari S. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur. J Intern Med 2009;20:411-4.
Czok M, Kramarczyk K. Association between depression and hemodialysis in patients with chronic kidney disease. Psychiatr Danubina 2017;29;499-503.
Garcia-llana H, Remor E, Peso G, Selgas R. The role of depression, anxiety, stress and adherence to treatment in dialysis patients’ health-related quality of life: a systematic review of the literature. Nefrología 2014;34:637-57.
Wilk AS, Hu JC, Chehal P, et al. National Estimates of mental health needs among adults with self-reported CKD in the United States. Kidney Int Rep 2022;7:1630-42.
Cristina A, Miranda AS, Rocha NP, Teixeira AL. Neuropsychiatric disorders in chronic kidney disease. Front Pharmacol 2019;10:1-11.
Shirazian S, Grant CD, Aina O, et al. Depression in chronic kidney disease and end-stage renal disease: Similarities and differences in diagnosis, epidemiology, and management. Kidney Int Rep 2016;2:94-107.
Burazeri G, Goda A, Sulo G, et al. Financial loss in pyramid saving schemes, downward social mobility and acute coronary syndrome in transitional Albania. J Epidemiol Commun Health 2008;62:620-6.
Mone I, Kraja B, Roshi E, Burazeri G. Overview on health status of the Albanian population. SEEJPH 2022;4:295.
Institute of Statistics, Albania. Key data, 2022. Available from: http://www.instat.gov.al/al/statistika/t%C3%AB-dh%C3%ABna-ky%C3%A7e/
Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease estimates. Available from: https://vizhub.healthdata.org/gbd-results/
Chen F, Wang M, Jiang Y. Prevalence of chronic kidney disease and metabolic related indicators in Mianzhu, Sichuan, China. Front Public Health 2024;11:1252110.
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One 2016;11:e0158765.
Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 2015;88:950-7.
Martinez R, Lloyd-Sherlock P, Soliz P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study. Lancet Glob Health 2020;8:e511-23.
Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011;80:17-28.
Zhang L, Long J, Jiang W, et al. Trends in chronic kidney Disease in China. N Engl J Med 2016;375:905-6.
Chen Y, Dabbas W, Gangemi A, et al. Obesity management and chronic kidney disease. Semin Nephrol 2021;41:392-402.
Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395:1-13.
Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: refer¬ence and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 2018;392:2052-90.
Zhakhinaa G, Mussinaa K, Yerdessova S, et al. Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030. Renal Failure 2024;46:2326312.

How to Cite

Duli, M., Dika, Q., Petrela, E., & Burazeri, G. (2024). Distribution of episodes of kidney diseases admitted at the University Hospital Center “Mother Teresa” in Tirana, Albania, during the period 2010-2023 . Healthcare in Low-Resource Settings. https://doi.org/10.4081/hls.2024.12927